Peramivir, Rapivab FLU Treatment
Contract Overview
Contract Amount: $34,660,000 ($34.7M)
Contractor: Biocryst Pharmaceuticals Inc
Awarding Agency: Department of Health and Human Services
Start Date: 2018-09-01
End Date: 2023-08-31
Contract Duration: 1,825 days
Daily Burn Rate: $19.0K/day
Official Description: PERAMIVIR, RAPIVAB FLU TREATMENT
Place of Performance
Location: North Carolina, 27703